Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone reflects a high level of interest and engagement, with posts supporting the study's conclusion that conservative treatment can be as effective as invasive procedures for stable coronary disease. Examples include references to the NEJM paper, debates about clinical practice modifications, and detailed analyses of trial data, demonstrating how the publication influences ongoing discussions in cardiology about appropriate treatment strategies and patient management.
Most discussions support the findings that conservative management is as effective as invasive strategies in stable coronary disease, reflecting agreement with the study's implications.
Posts show high interest, with many referencing the NEJM publication, emphasizing its significance in cardiology and including detailed comments and links.
The discussions actively analyze trial data, question clinical practices, and include varied example cases, indicating deep engagement.
The widespread sharing of the article and its implications suggests a strong impact on current clinical approaches and future research directions.
@altcap Decades of randomized data show no survival benefit to stenting stable coronary disease. https://t.co/TExzgpGWuT https://t.co/M7zcS4cnyA https://t.co/iGx9imdq8A https://t.co/9xRuU0qlFj https://t.co/qGV3O0uskl
@adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therapy can accelerate CACS and attenuates its predictive value https://t.co/pOdYj6mFBu 2) Most CCS trials excluded LM https://t.co/ZKMfTmng5P 3) Most elderly adjust
The ISCHEMIA Trial: Initial Invasive or Conservative Strategy for Stable coronary Disease? via @LeenAlblaihed https://t.co/J4lWmz2SQZ #ISCHEMIAtrial #FOAMed #ACS https://t.co/f5nDrRjZIF
Jeff Nelson claims stents are useless based on trials such as the ISCHEMIA trial. This is SUPER dishonest. The overwhelming majority of stents in the USA are placed in emergency settings, where the data shows they clearly DO help https://t.co/xSFIMk7x9Z https://t.co/R5EgPDE3pK https://t.co/bM0eZi2QFX
Clarity? Why do you suggest that an abnormal second degree derivative of ischemia warrants revascularization? Ever hear of the ISCHEMIA trial? Check it out: https://t.co/2EU887Ou19 https://t.co/xAkWHGB5KF
@aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstein @ZainabDakhil2 @hvanspall @vass_vassiliou @biljana_parapid #ESCCongress Per #IschemiaTrial if no LM disease & preserved LVEF>>optimize anti-angina med Rx & modify RF IRL “Widow maker” is engraved in too many patients (sadly docs too) @nejm https://t.co/5S67EFGiPX https://t.co/CLRxh8Ap34
Do plant-based diets reverse heart disease today we look at new scans showing reversal of an 80% blockage in a patient who followed a no-oil plant-based diet. We also discuss why some patients fail and compare invasive…
This week in cardiology, John Mandrola MD discusses findings that stroke rates in AF patients vary widely across studies, highlighting discrepancies between predicted and observed risks and emphasizing the need for…
This week in cardiology, we explore prediction models versus clinical judgment, CCTA quantification of atherosclerosis, and the latest on AF ablation, LAAO devices, and HF therapy. The study compares invasive and…
This video discusses Pulsed Field Ablation as a new treatment for persistent atrial fibrillation, highlighting its potential advantages over traditional methods and examining current research and clinical trials for…
Patients with three-vessel coronary artery disease had better outcomes with coronary artery bypass grafting (CABG) than with fractional flow reserve (FFR)-guided PCI. This week's podcast discusses key findings and…
This week’s podcast discusses how breastfeeding is linked to lower cardiovascular disease risks in mothers. An analysis of over 1.1 million women reveals significant health benefits, particularly a reduced incidence of…
This week's podcast discusses the importance of dual antiplatelet therapy duration for patients at high bleeding risk after drug-eluting stent placement. The study explores abbreviated therapy effectiveness compared to…
This podcast discusses the ISCHEMIA trial's findings on patients with stable coronary artery disease and ischemia. It explores the implications of these results for invasive versus conservative treatment strategies…
一方、これらを覆したのが、2019年AHAで発表されたISCHEMIA試験。中等度～重度の虚血を有するCCSにおいて，早期侵襲的治療戦略は保存的治療戦略にくらべ，虚血性心血管イベントや全死亡のリスクを低下させませんでした。 https://t.co/4mp1kr42lP
RT @DavidLBrownMD: Clarity? Why do you suggest that an abnormal second degree derivative of ischemia warrants revascularization? Ever hear…
冠動脈疾患(coronary artery disease: CAD)は ・急性冠症候群(ACS：心筋梗塞など） →血行再建術(PCI) ・安定CAD →年間10万件以上のCADに対するPCIか冠動脈バイパス術(CABG) ・ISCHEMIA試験(2020年) 安定CAD5,179例の予後はPCIorCABG施行と内科治療で差なし https://t.co/D53W9myAAe
RT @IndahSP_MD: To refresh our memory on #ISCHEMIATrial Read here: https://t.co/FWfrt9EYsX As an early career interventionalist, the ISCH…
RT @IndahSP_MD: To refresh our memory on #ISCHEMIATrial Read here: https://t.co/FWfrt9EYsX As an early career interventionalist, the ISCH…
To refresh our memory on #ISCHEMIATrial Read here: https://t.co/FWfrt9EYsX As an early career interventionalist, the ISCHEMIA trial was a wake-up call — it showed that in stable patients with moderate-to-severe ischemia, jumping straight to PCI doesn’t necessarily improve hard https://t.co/YYkC3qv4bg
@Dr_ppooohh_bot ISCHEMIA試験のインパクトは大きかったですが、 亜硝酸やCCBで ・スパズムは抑制できても ・予後改善効果は得られない ことを認識しておくべきでは！ 《ISCHEMIA試験》 https://t.co/D53W9myAAe 《ex.硝酸薬》 https://t.co/IKL0RFFCX4
@altcap Decades of randomized data show no survival benefit to stenting stable coronary disease. https://t.co/TExzgpGWuT https://t.co/M7zcS4cnyA https://t.co/iGx9imdq8A https://t.co/9xRuU0qlFj https://t.co/qGV3O0uskl
Do Plant-Based Diets Reverse Heart Disease? https://t.co/QoEfRmPRlF via @YouTube
Initial Invasive or Conservative Strategy for Stable Coronary Disease | New England Journal of Medicine https://t.co/mhJ3ItepBl
https://t.co/jao7vEYjax
RT @mirvatalasnag: @adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therap…
RT @mirvatalasnag: @adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therap…
RT @mirvatalasnag: @adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therap…
RT @mirvatalasnag: @adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therap…
RT @mirvatalasnag: @adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therap…
RT @mirvatalasnag: @adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therap…
@nadig_cardio You can definitely get a stress test- the question is what do you do if you find high risk findings on MPI ( not talking about this particular patient who may have obstructive LM disease - would need coronary CTA or cath to exclude ) https://t.co/Bw3WNCpgZn
@adityadoc1 This particular case teaches us a lot & decision making is not so black n white: 1) Intensive Statin therapy can accelerate CACS and attenuates its predictive value https://t.co/pOdYj6mFBu 2) Most CCS trials excluded LM https://t.co/ZKMfTmng5P 3) Most elderly adjust
RT @brhmrby: Link to the article: https://t.co/9XNzJcF1PE @Lina_Ayasrah @jolee_2022 @AbdulkaderMoh99 @sean_overy @_MeghanaIyer
RT @brhmrby: Link to the article: https://t.co/9XNzJcF1PE @Lina_Ayasrah @jolee_2022 @AbdulkaderMoh99 @sean_overy @_MeghanaIyer
Link to the article: https://t.co/9XNzJcF1PE @Lina_Ayasrah @jolee_2022 @AbdulkaderMoh99 @sean_overy @_MeghanaIyer
@JeffA47854828 @skathire Who cares what the calcium score is. If it’s high take a statin. Were you having angina? If not, why go looking for obstructive disease? So you could stent something? What would that accomplish? https://t.co/C2USyKCKje
@kaitlyn_mcsurdy ISCHEMIA https://t.co/tXaQ0GcA4d PEN-FAST https://t.co/Ea57hKTk2n EMPA-KIDNEY https://t.co/iwwARGuQif
In stable CAD with moderate to severe ischemia (excluding unprotected LM disease, LVEF <35%, NYHA III/IV, unacceptable angina with medical Rx), PCI was not shown to reduce CV death or CV events. (ISCHEMIA. NEJM 2020; 382:1395-1407) https://t.co/a6mhaE7SdX https://t.co/HmDAMJelVi
Thank you Jia Hong Chen, DO, for an excellent presentation on Initial Invasive or Conservative Strategy for Stable Coronary Disease for our journal club! https://t.co/seY9kg9Hh3
安定狭心症などの慢性冠症候群はPCIとかでなくお薬でも劣らないぜ Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/ygIm6HNsWM
RT @okuno_: 元論文 https://t.co/iintPVzNpB
元論文 https://t.co/iintPVzNpB
@ecgandrhythmRoe @The_Nanashi_O @anais_dahoumane @ecgrhythms @ECGEPSCADEVICE https://t.co/scd0GYdpjS Just dropping this off ok bye.
Multiple studies suggest conservative management of stable angina has approx same rates of MI and deaths: "Initial Invasive or Conservative Strategy for Stable Coronary Disease" https://t.co/dx6QQL1MlV
@TheEMboardround @UKheartresearch @divaka_perera @hollymorgs @DrMattRyan @REVIVED_BCIS2 @BCIS_uk @TheBHF PCI for what? Angina? HF? Or ACS? Starting with the arrhythmia analysis of REVIVED would probably be like starting with fourth or fifth book in a series. If you’re thinking stable angina, try COURAGE first: https://t.co/i3fH1eyAtu Then move to ISCHEMIA: https://t.co/scd0GYdpjS
RT @jsenior64: @gustavobonzon @omendiz Recordar que el manejo del síndrome coronario crónico es médico. Que las variables que considerábamo…
@gustavobonzon @omendiz Recordar que el manejo del síndrome coronario crónico es médico. Que las variables que considerábamos de alto riesgo no fueron refrendadas en el estudio ISCHEMIA para definir intervencionismo. https://t.co/nBd2arkrRq
ISCHEMIA Trial: No ⬇️ in risk of ischemic CV events or mortality in stable coronary artery disease pts who had initial PCI vs initial med Rx then PCI. https://t.co/ziEaGGZqfn #MedEd #MedX #MedTwitter #CardioTwitter #CardioX
@stefankmil Would probably replace this with ISCHEMIA personally. https://t.co/tXaQ0GcA4d
https://t.co/O6bEm2yfMi https://t.co/3OXhQbBrUM
RT @DavidLBrownMD: Clarity? Why do you suggest that an abnormal second degree derivative of ischemia warrants revascularization? Ever hear…
RT @DavidLBrownMD: Clarity? Why do you suggest that an abnormal second degree derivative of ischemia warrants revascularization? Ever hear…
RT @DavidLBrownMD: Clarity? Why do you suggest that an abnormal second degree derivative of ischemia warrants revascularization? Ever hear…
Clarity? Why do you suggest that an abnormal second degree derivative of ischemia warrants revascularization? Ever hear of the ISCHEMIA trial? Check it out: https://t.co/2EU887Ou19 https://t.co/xAkWHGB5KF
@atifrana81 @ShipraAryaMD @DartmthSurgHSR @DouglasEWood1 @maryhawn @DHStoneMD @VeteransHealth @vahsrd @AHAScience @heatherlgornik @VascularSVS @AWBeckMD @jmills1955 Hard to believe doing something helps in a non-ACS setting with this trial. Putting in a pro-thrombotic stent doesn’t sound good to me before surgery, especially CLTI that can’t wait 90 days. https://t.co/BOi2JuyXRH
@anujtiwari11 https://t.co/KTn3KfqXQJ https://t.co/nk3BYu6kni Both the trials show that revascularization is not superior Medical Mx but can be considered in case of 1)persistent angina despite optimum medical therapy 2) Triple vessel disease/ left main coronary artery disease with LV dysfun
Have met people who have had coronary artery stents despite having no symptoms. Tried to find RCT evidence for this but found nothing - seems to be a good example of low value care. @PaulGlasziou @clara_chow @AElshaug I did find this - ISCHEMIA trial. https://t.co/mzVVtnxxnG
Eat plants, exercise in sun, sleep 7-8 hours cardiologists don't treat cause of CAD Do Plant-Based Diets Reverse Heart Disease? https://t.co/PzERIm6lnc via @YouTube
.#Ischemia trial @NEJM 2020: no difference in risk of ischaemic CV events or any cause death, between invasive vs conservative strategy in stable CAD+ moderate to severe ischaemia at 3.2 yrs. Positively transformed cardiology #CardioTwitter @mmamas1973 DOI: 10.1056/NEJMoa1915922 https://t.co/nEcxzFEtdT
Flow simulation of coronary angio said to “improve outcomes” by reducing “unnecessary cath lab.” What is unnecessary vs necessary cath for stable angina? Based on cad rads table? According to ISCHEMIA rct, initial invasive+meds vs meds = no difference. https://t.co/jkavzPDvKQ
REFERENCES 1. Original ISCHEMIA results publication: 10.1056/NEJMoa1915922 2. HF subgroup analysis: 10.1161/CIRCULATIONAHA.120.050304 3. ISCHEMIA population ischemia severity: 10.1161/CIRCULATIONAHA.120.049755 Clinical implications (2021 review) 1. 10.1007/s11886-021-01470-x
@serioustaurean https://t.co/zyELxUI4Vl
https://t.co/8OCsWwpdTE
@iQ_cath @GEICC3 @GreggWStone @wfearonmd @webmd11 @ajaykirtane @SrihariNaiduMD @JEscaned @sbrugaletta @MarcoJe80135689 https://t.co/2EU887NWbB
D.J. Maronらの「Initial Invasive or Conservative Strategy for Stable Coronary Disease」から、安定冠動脈疾患に対して血行再建術を施行しても生命予後に対しては大きな変化がないと判明しています。
2/ ISCHEMIA randomized approx 6K patients w/ stable CAD and mod-large ischemia on non invasive testing to optimal medical therapy versus initial invasive strategy CV events/death did not defer b/w groups at median 3 yr f/u. https://t.co/ST2TJlhT2m
@nntaleb @Medawar_ Prof Read this too https://t.co/sanPkcNKvL
RT @AugoustidesJohn: Initial Invasive or Conservative Strategy for Stable Coronary Disease: The ISCHEMIA Trial and Its Clinical Implication…
RT @AugoustidesJohn: Initial Invasive or Conservative Strategy for Stable Coronary Disease: The ISCHEMIA Trial and Its Clinical Implication…
RT @AugoustidesJohn: Initial Invasive or Conservative Strategy for Stable Coronary Disease: The ISCHEMIA Trial and Its Clinical Implication…
RT @JCVAonline: Initial Invasive or Conservative Strategy for Stable #Coronary Disease: The ISCHEMIA Trial and Its Clinical Implications #T…
Initial Invasive or Conservative Strategy for Stable #Coronary Disease: The ISCHEMIA Trial and Its Clinical Implications #Therapy https://t.co/3PSH2XPBFA
Initial Invasive or Conservative Strategy for Stable Coronary Disease: The ISCHEMIA Trial and Its Clinical Implications #choices https://t.co/KsdalU9D2i
@shashiiyengar @DrPaulMason Also https://t.co/N161MyGW4T
@DrPaulMason https://t.co/N161MyGW4T
@SossouMd @ACCinTouch @escardio @JAMACardio @NEJM https://t.co/lbpGX2cqAO
RT @miguelcainzos23: 6. After the ISCHEMIA trial results, in ISCHEMIA-like patients with stable coronary disease, which is in your opinion,…
RT @miguelcainzos23: 6. After the ISCHEMIA trial results, in ISCHEMIA-like patients with stable coronary disease, which is in your opinion,…
6. After the ISCHEMIA trial results, in ISCHEMIA-like patients with stable coronary disease, which is in your opinion, the major driver of ASCVD risk? https://t.co/ei4faRDcUv
RT @mirvatalasnag: @aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstei…
RT @mirvatalasnag: @aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstei…
RT @mirvatalasnag: @aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstei…
RT @mirvatalasnag: @aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstei…
RT @mirvatalasnag: @aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstei…
@aayshacader @AChoiHeart @ANazmiCalik @ncurzen @VijayKunadian @VietHeartPA @VDelgadoGarcia @rladeiraslopes @RonBlankstein @ZainabDakhil2 @hvanspall @vass_vassiliou @biljana_parapid #ESCCongress Per #IschemiaTrial if no LM disease & preserved LVEF>>optimize anti-angina med Rx & modify RF IRL “Widow maker” is engraved in too many patients (sadly docs too) @nejm https://t.co/5S67EFGiPX https://t.co/CLRxh8Ap34
Initial Invasive or Conservative Strategy for Stable Coronary Disease by Salvador Cruz-Flores & team #stroketexas #stroke #srokeresearch #reseach https://t.co/3KzLFkbPf8 https://t.co/OkjuZ8LVYE
RT @jelevenson: @a_l_bailey @MichaelEmeryMD @hevalkellimd @SamOJonesMD @timir_paul @nrajag @glenn_hirsch @cardiojaydoc02 @biljana_parapid @…
@a_l_bailey @MichaelEmeryMD @hevalkellimd @SamOJonesMD @timir_paul @nrajag @glenn_hirsch @cardiojaydoc02 @biljana_parapid @KBerlacher @akates1 @dcscant @cardiowiis @RickChazal @cardio10s @mmamas1973 https://t.co/WSsm3dwuT3 ISCHEMIA published only Apr 2020. Provides safety data to change our paradigm for how we dx and rx CAD.
@ChristosArgyrop @srmkidney @askrenal Ischemia main study not much different https://t.co/tPo9RV9T8g
RT @ZaidAlMarzooq: 4⃣ These findings do not reflect the impact of more recent trials, like ORBITA and ISCHEMIA, that future studies will ne…
4⃣ These findings do not reflect the impact of more recent trials, like ORBITA and ISCHEMIA, that future studies will need to evaluate. https://t.co/aywJHUw1fv https://t.co/2AzRjID7t5
@islaut1 @stephensenn I think an important difference is between choosing the analysis after looking at the data and checking the assumptions after the analysis. See the link @stephensenn posted. You can also prespecify alternatives conditional on violation of assumptions as in https://t.co/uuLtvUKGEZ
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/fc7bCxkcVQ
@ClownBasket Just look at the number one killer heart disease: https://t.co/Grn2vlABfP https://t.co/ozp1s8QMYR
Made for each other, https://t.co/O6bEm2yfMi https://t.co/nGCPdIzSxx
@SahilAgrawalMD @GreggWStone Most trials exclude CCS 3 angina or lump it together with CCS 0/1/2 https://t.co/Onz37v8mQH ISCHEMIA Trial used sensitive definition for procedural MI but ltm less MI in PCI https://t.co/guLMlQddZE this patient may not fit nicely into any prev study, so clinical judgement needed
Named a @NEJM notable article of 2020, "Initial Invasive or Conservative Strategy for Stable Coronary Disease" examines strategies for reducing risk of ischemic cardiovascular events or death. https://t.co/jvYAcaP5cG
3. Medical management as effective as PCI in stable angina https://t.co/n0jcZrBQJd and https://t.co/G5UZPTwkN3
@Cardiotweets83 @Cardio_ciencias @VazyurVasquez @wikimagen @ecardioimage @iamritu @purviparwani @VLSorrellImages @JGrapsa @jpcostabel @josejgdnews @carlos_sierra @hatemsoliman ISCHEMIA trial https://t.co/Ufodj53s79
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM ....ISCHEMIA trial of stents vs medical management https://t.co/ObmVFBk9VD
Unbelievable reversals... Do Plant-Based Diets Reverse Heart Disease? https://t.co/WEKN5o0ACP via @YouTube
RT @GenetesisInc: One of the most ground-breaking trials in cardiovascular history, known as ISCHEMIA, demonstrated that invasive treatment…
One of the most ground-breaking trials in cardiovascular history, known as ISCHEMIA, demonstrated that invasive treatment isn’t necessarily better treatment in stable coronary disease. Read the full study here: https://t.co/erqdw0qMuh https://t.co/oAzL4jH5Jw
@LaraAHayes @danistap @DukeHospitalist @emilysignor1 @JoelBoggan @AmandaBreviu @KatieLappeMD @LizHankollariMD @onedoctormama @SaumilChudgar @SonjaRaaum @DavidLSimel @JPShoup @CiarkowskiMD @VChoksi @sjenkinsmd @lastweekinmed 2/2 and not necessarily practice-changing for me, but the ISCHEMIA trial seemed like a big deal in the cardiology world. https://t.co/yDt1Pa8izS
Visit https://t.co/jvYAcaxul8 to view "Initial Invasive or Conservative Strategy for Stable Coronary Disease, a paper by #StanDOM's David Maron, @HeartBobH & colleagues. Their work was recently named a @NEJM notable article of 2020.
ISCHEMIA Trial Initial Invasive or Conservative Strategy for Stable Coronary Disease https://t.co/x1ga6SHKsx https://t.co/Ucm1dn04VE
RT @StanfordDeptMed: Authored by #StanDOM's David Maron, @HeartBobH & colleagues, "Initial Invasive or Conservative Strategy for Stable #C…
Authored by #StanDOM's David Maron, @HeartBobH & colleagues, "Initial Invasive or Conservative Strategy for Stable #CoronaryDisease" was named a @NEJM notable article of 2020. View the paper here: https://t.co/jvYAcaxul8
https://t.co/IT9kA5POpl
Jeff Nelson claims stents are useless based on trials such as the ISCHEMIA trial. This is SUPER dishonest. The overwhelming majority of stents in the USA are placed in emergency settings, where the data shows they clearly DO help https://t.co/xSFIMk7x9Z https://t.co/R5EgPDE3pK https://t.co/bM0eZi2QFX
RT @MidAmericaHeart: Two impactful @NEJM manuscripts from lead author @jspertus from @MidAmericaHeart on health status from the ISCHEMIA tr…
https://t.co/ujskbsQZyM
RT @styrohome: Do Plant-Based Diets Reverse Heart Disease? https://t.co/XnC9lnHLfl via @YouTube
Do Plant-Based Diets Reverse Heart Disease? https://t.co/XnC9lnHLfl via @YouTube
Do Plant-Based Diets Reverse Heart Disease? https://t.co/Eck8uroddv via @YouTube
Endpoint primario sin diferencias significativas a 5 años. El tratamiento médico óptimo parece ser una buena opción en pacientes con angina no discapacitante. https://t.co/PfupxqknUy
Great Resident Grand Rounds today by future Chief and current PGY 3 Dr. Gasper and faculty mentor Dr. Kanei @MountSinaiHeart on the ISCHEMIA group trial in NEJM this past April #cad #ischemia #meded #medres #HeartHealth https://t.co/PamXv5JGCm
This is a very informative interpretation of the ISCHEMIA trial (https://t.co/rUdJyCmpuc): https://t.co/4YfjHOf8nQ
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/ovonaPJk4z
@dscharf3 @f2harrell @kaulcsmc Would really appreciate your feedback. https://t.co/M4pdJMLXrS
Journal clubs x 2 today!! This morning, we discussed antibiotic stewardship from JAMA’s empiric anti-MRSA vs standard therapy and NEJM’s initial invasive or conservative strategy for stable coronary disease with Co-residents then tonight #NephJc discussion on the STARRT AKI!!
こちらURLがeditorialになっていました 主解析の論文はこちらです N Engl J Med 2020;382:1395-407. 10.1056/NEJMoa1915922 by 日循サポーター @JCIRC_IPR #20JCS
RT @SABOURETCardio: So many (useful ?) debates after #ischemia to conclude that "one size doesn't fit all". Every ischemia should be docume…
RT @SABOURETCardio: So many (useful ?) debates after #ischemia to conclude that "one size doesn't fit all". Every ischemia should be docume…
So many (useful ?) debates after #ischemia to conclude that "one size doesn't fit all". Every ischemia should be documented before a (potential) PCI and a LM stenosis should be identified by a CT. https://t.co/fCACwBnsxw
Wexham cardiology journal club paper of the week @JasonChaiKL @JosephineManse2 @DrJoshuaChai @nav4879 https://t.co/npj1l53nXP
@DrAseemMalhotra https://t.co/d7iqs8siEU
Very interesting https://t.co/kVkD3gnjEQ Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/39gfBtUrQS
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM. Another study supporting a conservative approach first. https://t.co/iR8KSrvwex
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/NjTiyVLyGT
Enjoyed the analysis of the ISCHEMIA Trial -https://t.co/D2o141ODfa - by @SVRaoMD and panel @SCAI 2020; our take-away - an invasive strategy in SIHD provides a SAQ benefit in those experiencing *frequent* episodes of angina, but no mortality or MI benefit
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/0LWOH2XU4L
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/0j4z75LRof
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/n38gJpwXjy
RT @srrezaie: The ISCHEMIA Trial: Initial Invasive or Conservative Strategy for Stable coronary Disease? via @LeenAlblaihed https://t.co/J…
RT @srrezaie: The ISCHEMIA Trial: Initial Invasive or Conservative Strategy for Stable coronary Disease? via @LeenAlblaihed https://t.co/J…
RT @srrezaie: The ISCHEMIA Trial: Initial Invasive or Conservative Strategy for Stable coronary Disease? via @LeenAlblaihed https://t.co/J…
https://t.co/T6lQLxol7f
RT @srrezaie: The ISCHEMIA Trial: Initial Invasive or Conservative Strategy for Stable coronary Disease? via @LeenAlblaihed https://t.co/J…
The ISCHEMIA Trial: Initial Invasive or Conservative Strategy for Stable coronary Disease? via @LeenAlblaihed https://t.co/J4lWmz2SQZ #ISCHEMIAtrial #FOAMed #ACS https://t.co/f5nDrRjZIF
Compartimos el artículo del Comité de Cardiopatía isquémica: Initial Invasive or Conservative Strategy for Stable Coronary Disease. ISCHEMIA TRIALS por el Dr. Esteban Frontera https://t.co/B9fLslceXH
Initial Invasive or Conservative Strategy for Stable Coronary Disease. https://t.co/HDDuzmlYEt
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/uysXGdMEi6
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/szVM52rHMp
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/htxNEGEFbY
No difference between strategies in stable CAD with moderate to severe ischemia #cardiology #medicine Initial Invasive or Conservative Strategy for Stable #Coronary Disease | NEJM https://t.co/r8rXtm0OuJ
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/xMdFEFc0wa
Initial Invasive or Conservative Strategy for Stable Coronary Disease. - https://t.co/pvauRLpYk3 https://t.co/FfDNJnVVjM
RT @gabrielsteg: ISCHEMIA is published ! Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/Kr2AlBrc…
RT @paomorejon:
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/l1mIJXAmHb #CardioJapan 18年ほど前、榊原記念病院レジデントの頃 大々ベテランのDrにstableAPにむやみに手をだすな と何度も指導されたのを改めて思い出す 大事だなぁ。。 https://t.co/CO693HIaTF
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/rRdehK2BSp
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
RT @paomorejon:
RT @paomorejon:
RT @paomorejon:
RT @paomorejon:
Initial Invasive or Conservative Strategy for Stable Coronary Disease https://t.co/IN0L0GKnqL
RT @paomorejon:
RT @ernestocardio: Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/oyi3h7KIOf @CardiologiaSVC @se…
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
RT @gabrielsteg: ISCHEMIA is published ! Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/Kr2AlBrc…
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/TWojN1bKp1
RT @acorderofort: The ISCHEMIA Trial finally published!!! Initial Invasive or Conservative Strategy for Stable Coronary Disease Some fresh…
RT @paomorejon:
RT @gcfmd: ISCHEMIA trial now published. Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/js53N4w…
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM #ACC20 #ISCHEMIA https://t.co/sHpzMnebTl
RT @paomorejon:
安定狭心症の初期治療はインタベ押せ押せじゃなくなるのでしょうか？ #ピボタル試験 になるとネットもざわついています。 Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/O6nRl39V10
RT @ernestocardio: Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/oyi3h7KIOf @CardiologiaSVC @se…
RT @ZainabASamad: Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM @SarahNadeemMD @ShahabHunaina @m_tahak…
RT @paomorejon:
RT @paomorejon:
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/OHwjTPCuDw
RT @paomorejon:
RT @gcfmd: ISCHEMIA trial now published. Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/js53N4w…
RT @Yuki_Sahashi: ついにISCHEMIA試験がああああああああ。 読むぞ Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/R…
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @paomorejon:
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
RT @gcfmd: ISCHEMIA trial now published. Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/js53N4w…
RT @paomorejon:
RT @paomorejon:
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
RT @paomorejon:
RT @doctorchecho: Ya están disponibles los resultados del ISCHEMIA. Ya no valdrá el "cate para todos" en angina estable. Initial Invasive…
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/JG1SXEoXfi
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @acorderofort: The ISCHEMIA Trial finally published!!! Initial Invasive or Conservative Strategy for Stable Coronary Disease Some fresh…
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @gcfmd: ISCHEMIA trial now published. Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/js53N4w…
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @gcfmd: ISCHEMIA trial now published. Initial Invasive or Conservative Strategy for Stable Coronary Disease | NEJM https://t.co/js53N4w…
RT @paomorejon:
Initial Invasive or Conservative Strategy for Stable Coronary Disease: ISCHEMIA trial published in @NEJM https://t.co/h6x1GM6RRT
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
RT @paomorejon:
RT @paomorejon:
RT @paomorejon:
RT @paomorejon:
RT @StanfordCVI: Congratulation to David Maron (chief of Stanford Prevention Research Center) and #ISCHEMIA investigators for publishing @N…
MM
LD
AP